SLC25A51P2

Across TCGA pan-cancer cohorts, SLC25A51P2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated SLC25A51P2 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher SLC25A51P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SLC25A51P2 expression acts as an unfavorable survival marker, although some lineages such as COAD show a favorable association.

LUSC, ACC, and KIRC are the cancer types where SLC25A51P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.054	0.780	<.001	63	view →
ACC	DFS	Tertile	All	0.119	0.656	<.001	60	view →
KIRC	DFS	Tertile	III,IV	0.215	0.512	.008	54	view →
BRCA	OS	Tertile	II,III,IV	0.769	0.916	.005	54	view →
READ	OS	Tertile	II,III,IV	0.056	0.934	<.001	54	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
OV	OS	Tertile	IV	0.305	0.765	.016	18	view →
PCPG	OS	Tertile	All	0.505	0.945	.004	18	view →
LUAD	DFS	Tertile	All	0.320	0.666	.004	9	view →
COAD	DFS	Tertile	All	1.000	0.505	.037	6	view →
STAD	DFS	Quartile	All	0.464	0.573	.021	5	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

SLC25A51P2–LUSC (OS)

Open the LUSC breakdown →